Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fineman

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Ophthalmology. Retina|February 12, 2026
Eyes Achieving Absence of Diabetic Macular Edema and Very Good Vision: A Post Hoc Analysis of DRCR Network Protocol ACRoselind Ni, Bita Momenaei, Raziyeh Mahmoudzadeh, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|August 7, 2015
Combined 23-Gauge PPV and Scleral Buckle Versus 23-Gauge PPV Alone for Primary Repair of Pseudophakic Rhegmatogenous Retinal DetachmentVikram J Setlur, Nadim Rayess, Sunir J Garg, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 23, 2021
Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)Kimberly A Drenser, Dante J Pieramici, Joseph M Gunn, et al.
Diabetes Care|March 1, 2003
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trialPriscilla A Hollander, Philip Levy, Mark S Fineman, et al.
The Journal of Allergy and Clinical Immunology|July 1, 1995
Establishing practice parametersI L Bernstein, J B Moore, S Fineman, et al.
Diabetes Technology & Therapeutics|May 23, 2002
Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetesRobert E Ratner, Laura L Want, Mark S Fineman, et al.
Annals of Allergy|September 1, 1993
Establishing practice parameters: parameters for the diagnosis and treatment of asthmaI L Bernstein, J Blessing-Moore, S Fineman, et al.
Diabetes, Obesity & Metabolism|January 13, 2012
Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatmentMark S Fineman, K F Mace, M Diamant, et al.
Journal of Vitreoretinal Diseases|February 23, 2026
Outcomes after a Physician-directed Pause of Anti-Vascular Endothelial Growth Factor Therapy in Eyes with Branch Retinal Vein OcclusionBita Momenaei, Joseph R Weintraub, Dawson C Williams, et al.
European Journal of Endocrinology|November 18, 2000
Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled studyJ O Jørgensen, A M Rosenfalck, S Fisker, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Ophthalmology. Retina|February 12, 2026
Eyes Achieving Absence of Diabetic Macular Edema and Very Good Vision: A Post Hoc Analysis of DRCR Network Protocol ACRoselind Ni, Bita Momenaei, Raziyeh Mahmoudzadeh, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|August 7, 2015
Combined 23-Gauge PPV and Scleral Buckle Versus 23-Gauge PPV Alone for Primary Repair of Pseudophakic Rhegmatogenous Retinal DetachmentVikram J Setlur, Nadim Rayess, Sunir J Garg, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 23, 2021
Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)Kimberly A Drenser, Dante J Pieramici, Joseph M Gunn, et al.
Diabetes Care|March 1, 2003
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trialPriscilla A Hollander, Philip Levy, Mark S Fineman, et al.
The Journal of Allergy and Clinical Immunology|July 1, 1995
Establishing practice parametersI L Bernstein, J B Moore, S Fineman, et al.
Diabetes Technology & Therapeutics|May 23, 2002
Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetesRobert E Ratner, Laura L Want, Mark S Fineman, et al.
Annals of Allergy|September 1, 1993
Establishing practice parameters: parameters for the diagnosis and treatment of asthmaI L Bernstein, J Blessing-Moore, S Fineman, et al.
Diabetes, Obesity & Metabolism|January 13, 2012
Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatmentMark S Fineman, K F Mace, M Diamant, et al.
Journal of Vitreoretinal Diseases|February 23, 2026
Outcomes after a Physician-directed Pause of Anti-Vascular Endothelial Growth Factor Therapy in Eyes with Branch Retinal Vein OcclusionBita Momenaei, Joseph R Weintraub, Dawson C Williams, et al.
European Journal of Endocrinology|November 18, 2000
Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled studyJ O Jørgensen, A M Rosenfalck, S Fisker, et al.
Pageof 11